Phibro Animal Health | PAHC - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Phibro Animal Health

Phibro Animal Health reported $37.24M in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
Align Technology ALGN:US USD 832.38M 109.67M
ANI Pharmaceuticals ANIP:US USD 67.76M 19.53M
Bristol-Myers Squibb BMY:US USD 9B 128M
Corcept Therapeutics CORT:US USD 299.94M 233.61M
Depomed DEPO:US USD 68.6M 3.66M
Eli Lilly LLY:US USD 3.55B 1.48B
Endo International ENDP:US USD 903.61M 115.27M
Henry Schein HSIC:US USD 126M 9M
Idexx Laboratories IDXX:US USD 111.37M 1.18M
Knight Therapeutics Inc GUD:CN CAD 1.95M 1.65M
Nektar Therapeutics NKTR:US USD 76.96M 11.27M
Pacira PCRX:US USD 35.54M 68.59M
Patterson Companies PDCO:US USD 147.29M 7.01M
Phibro Animal Health PAHC:US USD 37.24M 31.18M
Prestige Brands PBH:US USD 58.49M 27.87M
Supernus Pharmaceuticals SUPN:US USD 58.44M 34.68M
Zoetis ZTS:US USD 2.1B 1.47B